Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Generics
67 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Parenterals
Trends Shaping the Dynamic Market for Parenterals
PAP-Q3-20-CL-018
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
PR-M02-20-NI-041
Market Prediction
Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth
PR-M01-20-NI-022
Generics
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
PR-M01-20-NI-021
M&A
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
PR-M01-20-NI-019
Generic
Amneal Announces Approval of Generic Version of Amicar®
PR-M09-19-NI-024
Generics
China Eases Generic Drug Market Shake-Up
PAO-M08-19-NI-001
Generics
FDA Approves First Generics of Lyrica
PR-M07-19-NI-060
FDA Approval
MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone
PR-M07-19-NI-045
Generics
Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition
PAO-M06-19-NI-004
Generics
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
PR-M05-19-NI-087
Generics
State Lawsuit Charges Generic Makers with Price Fixing
PAO-M05-19-NI-032
Generics
Being at the Right Place at the Right Time
PAP-Q2-2019-CL-033
Generics
Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States
PR-M05-19-NI-045
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
PAO-M05-19-NI-006
Opioids
FDA Grants Competitive Generic Therapy (CGT) Designation to Purdue Pharma’s Investigational Nalmefene HCl Injection
PR-M04-19-NI-080
Generics
The Generic Pharmaceutical Market in Kenya & Nigeria - Forecast to 2022
PR-M04-19-NI-079
Generics
Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States
PR-M04-19-NI-072
Generics
Par Pharmaceutical Begins Offering Generic Albuterol Sulfate
PAO-M04-19-NI-010
Generics
Finding the Right Product Platform: A Personal Perspective
PAP-Q1-2019-CL-034
Generics Manufacturing
Generics Manufacturing and Changing Equipment Needs
PAP-Q1-2019-CL-019
ANDA
Perrigo Confirms Patent Challenge for Generic Version of Nascobal®
PR-M03-19-NI-020
Opioids
Generic Suboxone Sublingual Film Launched
PAO-M03-19-NI-004
Generics
Roche Counters Generic Competition with New Cancer Treatments
PAO-M02-19-NI-022
1
3
»
